Today’s Cryptography Quiz is a multiple-choice question:
Is the following text (a) written in a secret code; or (b) nonsensically-randomized words; or (c) simple obfuscation; or (d) something else? The text is from the beginning of a press release issued by BioSante Pharmaceuticals:
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)– BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX – News) today announced top-line results from its two pivotal Phase III LibiGel (testosterone gel) efficacy trials. Initial analysis of the data from these trials shows that the trials did not meet the co-primary or secondary endpoints. Although there were no statistical differences in the endpoints, all results were in the appropriate directions.
[HINT: The text goes on to say: “LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in postmenopausal women, for which there is no FDA-approved product.”]
(Thanks to investigator Ivan Oransky for bringing this to our attention.)